glutathione and triple negative breast cancer Ratiometrically designed nanoprodrug for triple-negative treatment Activation of the eIF2α/ATF4 axis
Activation of the eIF2 ATF4 axis drives triple negative breast cancer radioresistance by promoting glutathione biosynthesis ScienceDirect glutathione autophagy Regulatory network of ferroptosis and by targeting oxidative stress defense using sulfasalazine in triple negative breast cancer Apoptosis and glutathione: beyond an Targeting the redox programmed cell death axis in breast cancer: from molecular mechanisms to therapeutic resistance Cell Death Discovery Glutathione depletion and dihydroorotate dehydrogenase inhibition actuated ferroptosis augment to surmount triple negative breast cancer ScienceDirect
Pay in 4 interest-free payments of $7.00 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6



